5th Mar 2019 17:20
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr B McNamara | |||
b) | Position/status | CEO, GSK Consumer Healthcare | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | American Depositary Shares ('ADSs')
ISIN: US37733W1053
| |||
b) | Nature of the transaction | Cash payout of £270,644.71 less applicable tax withholding in respect of 6,700.785 notional ADS following vesting of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award plan. | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| $40.39
| 6,700.785 |
| ||
|
|
|
| ||
d) | Aggregated information | n/a (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2019-03-04 | |||
f) | Place of the transaction
| n/a |
Related Shares:
Glaxosmithkline